On Demand Webinar: Current and future obesity services in the UK
In this second of a series of three webinars focussing on obesity, hosted by ABCD and GIRFT and supported by Novo Nordisk Ltd, Professor Barbara McGowan will present an update on current and future obesity services in the UK, and Susannah Howard will talk about the commissioning perspective.
This is a Novo Nordisk Sponsored meeting
Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.
Related Event
Current and future obesity services in the UK
Speakers
-
Susannah Howard
ICS Programme Director
Susannah Howard has worked in roles delivering transformation and change in health and care for most of her career. In her current role as ICS Programme Director, Susannah has worked closely with other local health and care leaders to develop Suffolk and North East Essex as one of the first Integrated Care Systems in the country. Originally trained as a psychologist, she worked in various national roles in mental health with The Royal College of Psychiatrists Research Unit, Department of Health and Commission for Health Improvement before moving to the East of England and leading the Eastern Development Centre from 2002-2010. She then established the unique NHS based business unit ‘Enable East’ for which she was named ‘Business Woman of the Year’ in the Essex Business Awards in 2013. She features annually as a Guest Lecturer in Project Management at Harvard University Extension School and has worked on several occasions with the World Health Organisation (WHO) in trauma affected countries including Sri Lanka and the West Bank and Gaza. Susannah has also successfully bid for and delivered grant funded programmes for the Big Lottery Fund totalling more than £12 million over the last 12 years. She is passionate about need for better understanding, support and treatment for those living with obesity and is a member of the national Strategic Council that advises the All Party Parliamentary Group on obesity. -
Professor Barbara McGowan
Professor Barbara McGowan is a Consultant Endocrinologist at Guy's and St Thomas' Hospital (GSTT) and Professor in Diabetes and Endocrinology at King’s College London. She was awarded a PhD from Imperial College London for investigating ‘The role of relaxin-3 on energy homeostasis and the hypothalamic-pituitary-axis’ and the role of gut hormones and other neuropeptides in appetite control.
She is R&D lead for Diabetes and Endocrinology at GSTT and the South London Specialty lead for the Metabolic and Endocrine research network. She leads the obesity bariatric service at GSTT where she manages patients with severe and complex obesity. Her areas of research interest are in gut hormones and appetite control, pharmacotherapy for obesity and remission of type 2 diabetes post-bariatric surgery. She is an investigator for several obesity clinical trials and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS.
Professor McGowan is a SCOPE National fellow, a member of the European Society for Endocrinology Policy and Advocacy Task Force and a member of the RCP Advisory Group on Weight and Health. She chairs the GIRFT/ABCD Obesity Task Force. She has served as Treasurer of the Society for Endocrinology and as a Trustee of the Association for the Study of Obesity.
-
Professor John Wilding
Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital – designated a Centre for Obesity Management by the European Association for the Study of Obesity.
John’s research team focusses on developing and evaluating treatments for obesity and diabetes. He has published over 350 papers, chapters and review articles, including clinical trials in diabetes and obesity, studies of adipocyte biology and metabolism.
He chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group.
He is a past Chair of the UK Association for the Study of Obesity, a member of the Royal College of Physicians Advisory Group on Nutrition, Weight and Health and past President of the World Obesity Federation.
